0001209191-18-014233.txt : 20180227 0001209191-18-014233.hdr.sgml : 20180227 20180227190144 ACCESSION NUMBER: 0001209191-18-014233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180223 FILED AS OF DATE: 20180227 DATE AS OF CHANGE: 20180227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andrews Audrey T. CENTRAL INDEX KEY: 0001568933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 18647368 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-23 0 0000070318 TENET HEALTHCARE CORP THC 0001568933 Andrews Audrey T. 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 0 1 0 0 SVP and General Counsel Common Stock 2018-02-23 4 M 0 4749 A 51397 D Common Stock 2018-02-23 4 F 0 1258 19.28 D 50139 D Common Stock 2018-02-23 4 M 0 7822 A 57961 D Common Stock 2018-02-23 4 F 0 1894 19.28 D 56067 D 2015 February Restricted Stock Units 2018-02-23 4 M 0 4749 0.00 D Common Stock 4749 0 D 2015 February Performance-Based Restricted Stock Units 2018-02-23 4 M 0 7822 0.00 D Common Stock 7822 0 D As previously reported, on February 25, 2015, the reporting person received a grant of 14,246 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 4,748 shares of common stock. The second vesting date occurred on February 24, 2017 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 4,749 shares of common stock. The third vesting date occurred on February 23, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 4,749 shares of common stock, as shown in Table I. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. On 2/25/15, the reporting person received a target grant of 14,246 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending 12/31/15. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded & 164.7% of the target grant was awarded; therefore, these RSUs vest in 1/3 increments on each of the 1st, 2nd & 3rd anniversaries of the date of grant. The 1st anniversary occurred 2/25/16, resulting in the vesting & settlement of 7,820 shares of common stock. The 2nd vesting date occurred 2/24/17 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting & settlement of 7,822 shares of common stock. The 3rd vesting date occurred 2/23/18 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting & settlement of 7,822 shares of common stock as shown in Table I. Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Anthony L. Shoemaker, as Attorney-in-Fact for Audrey T. Andrews 2018-02-27